← Back to Clinical Trials
Recruiting NCT06439979

NCT06439979 Rural Adult and Youth Sun Protection Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06439979
Status Recruiting
Phase
Sponsor University of Utah
Condition Melanoma (Skin)
Study Type INTERVENTIONAL
Enrollment 843 participants
Start Date 2024-04-08
Primary Completion 2029-08

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 7 Years
Study Type INTERVENTIONAL
Interventions
RAYS Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 843 participants in total. It began in 2024-04-08 with a primary completion date of 2029-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to help prevent skin cancer by improving the use of sun protective behaviors among youths living in rural communities in Utah and West Virginia.

Eligibility Criteria

Parent inclusion criteria: i. Adults who currently have children ages 3 and older years of age playing on participating sports teams in leagues serving rural areas in Utah or West Virginia (rural is defined as ≥4 by the RUCA or RUCC systems) ii. Live and/or work in rural communities in Utah or West Virginia (≥4 as defined by the RUCA or RUCC systems) Coach/leader inclusion criteria: i. Adults who serve as coaches or leaders of recreational sports (i.e. baseball/softball, soccer, flag football, etc.) teams or developmental programs serving children ages 3 and older ii. Live and/or work in rural areas of Utah or West Virginia (rural is defined as ≥4 by the RUCA or RUCC systems) Participant inclusion criteria for minor participants (ages 3 and older) are as follows: i. Live in rural communities and/or participate in sports leagues serving rural communities in Utah or West Virginia (≥4 as defined by the RUCA or RUCC systems). Participant inclusion criteria for key informant interviews are as follows: i. Adults who serve as leaders or who are affiliated with sports leagues or community groups serving rural youths and/or adults who currently have minor children 3 years of age or older playing on participating sports teams and/or adults who live and/or work in rural communities in Utah or West Virginia ((≥4 as defined by the RUCA or RUCC systems) Local sports leagues will be eligible to participate if they convene recreational sports (i.e. baseball/softball) teams or developmental programs (i.e. T-ball and coach pitch) for children ages 3 and older. Exclusion Criteria: * Adults and children who do not speak or read English will be excluded. * For individuals asked to complete surveys, individuals who have a medical or other condition (e.g., developmental delay) that would preclude their completion of these surveys will be excluded.

Contact & Investigator

Central Contact

Yelena P Wu, PhD

✉ yelena.wu@utah.edu

📞 8015850303

Principal Investigator

Yelena P Wu, PhD

PRINCIPAL INVESTIGATOR

University of Utah

Frequently Asked Questions

Who can join the NCT06439979 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 7 Years, studying Melanoma (Skin). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06439979 currently recruiting?

Yes, NCT06439979 is actively recruiting participants. Contact the research team at yelena.wu@utah.edu for enrollment information.

Where is the NCT06439979 trial being conducted?

This trial is being conducted at Salt Lake City, United States, Morgantown, United States.

Who is sponsoring the NCT06439979 clinical trial?

NCT06439979 is sponsored by University of Utah. The principal investigator is Yelena P Wu, PhD at University of Utah. The trial plans to enroll 843 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology